These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7305550)

  • 1. Liver cytosol protein binding may be not responsible for hepatic uptake of biliary contrast agents.
    Leyhausen G; Müller WE
    Arch Int Pharmacodyn Ther; 1981 Jul; 252(1):4-16. PubMed ID: 7305550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver slice uptake of intravenous and oral biliary contrast media.
    Müller WE; Stillbauer AE
    Arch Int Pharmacodyn Ther; 1980 Aug; 246(2):187-204. PubMed ID: 7436626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary contrast agents: comparative study about the binding to human plasma and the effect of human plasma on hepatic uptake.
    Müller WE; Stillbauer AE
    Pharmacology; 1981; 22(4):269-75. PubMed ID: 7267698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiology of biliary excretion of roentgenographic contrast media (author's transl)].
    Fuchs WA
    Radiologe; 1977 Feb; 17(2):64-9. PubMed ID: 322197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of intravenous and oral biliary contrast agents to human and bovine serum albumin.
    Müller WE
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Apr; 302(2):227-33. PubMed ID: 26028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the Y and Z hepatic proteins in the excretion of radiographic contrast materials.
    Sokoloff J; Berk RN; Lang JH; Lasser EC
    Radiology; 1973 Mar; 106(3):519-23. PubMed ID: 4684791
    [No Abstract]   [Full Text] [Related]  

  • 7. Vicarious excretion of contrast media.
    Lautin EM; Friedman AC
    JAMA; 1982 Mar; 247(11):1608-10. PubMed ID: 7062468
    [No Abstract]   [Full Text] [Related]  

  • 8. Inducible high-affinity binding site for benzo(a)pyrene in cytosol from rat liver.
    Mureşan Z; Stoica A; Stafidov N; Voiculetz N
    Neoplasma; 1987; 34(5):523-35. PubMed ID: 3320770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR structural studies of the supramolecular adducts between a liver cytosolic bile acid binding protein and gadolinium(III)-chelates bearing bile acids residues: molecular determinants of the binding of a hepatospecific magnetic resonance imaging contrast agent.
    Assfalg M; Gianolio E; Zanzoni S; Tomaselli S; Russo VL; Cabella C; Ragona L; Aime S; Molinari H
    J Med Chem; 2007 Nov; 50(22):5257-68. PubMed ID: 17915850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemical structure biliary excretion of iodine-containing contrast agents in hemoglobin-free perfused rat liver and in vivo (author's transl)].
    Azuma H; Oshino N
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(5):321-32. PubMed ID: 7203274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of silybin action, III. Resorption of the flavonolignane derivative silybin into rat liver cells (author's transl)].
    Sonnenbichler J; Mattersberger J; Hanser G
    Hoppe Seylers Z Physiol Chem; 1980 Nov; 361(11):1751-6. PubMed ID: 7450686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic uptake and biliary excretion of d-tubocurarine and trimethyltubocurarine in the rat in vivo and in isolated perfused rat livers.
    Meijer DK; Weitering JG; Vonk RJ
    J Pharmacol Exp Ther; 1976 Jul; 198(1):229-39. PubMed ID: 933009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic alpha 2 mu-globulin localizes to the cytosol of rat proximal tubule cells.
    Wang Y; Shia MA; Christensen TG; Borkan SC
    Kidney Int; 2000 Mar; 57(3):1015-26. PubMed ID: 10720954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding, nuclear translocation and biliary secretion of metabolites of 3'-methyl-N,N-dimethyl-4-aminoazobenzene during hepatocarcinogenesis in rats.
    Srinivasan K; Levine WG; Bhargava MM
    Xenobiotica; 1991 Jul; 21(7):961-9. PubMed ID: 1776271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structure-distribution-relationship approach leading to the development of Tc-99m mebrofenin: an improved cholescintigraphic agent.
    Nunn AD; Loberg MD; Conley RA
    J Nucl Med; 1983 May; 24(5):423-30. PubMed ID: 6842291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that interference with binding to hepatic cytosol binders can inhibit bile acid excretion in rats.
    Takikawa H; Sugiyama Y; Fernandez-Checa JC; Kuhlenkamp J; Ookhtens M; Kaplowitz N
    Hepatology; 1996 Jun; 23(6):1642-9. PubMed ID: 8675188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcellular and transnuclear transport of 3,5,3'-triiodothyronine in isolated hepatocytes.
    Mooradian AD; Schwartz HL; Mariash CN; Oppenheimer JH
    Endocrinology; 1985 Dec; 117(6):2449-56. PubMed ID: 4065040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro binding of L-triiodothyronine to receptors in rat liver nuclei. Kinectics of binding, extraction properties, and lack of requirement for cytosol proteins.
    Surks MI; Koerner DH; Oppenheimer JH
    J Clin Invest; 1975 Jan; 55(1):50-60. PubMed ID: 162784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic uptake, intracellular protein binding and biliary excretion of amethopterin.
    Strum WB; Liem HH
    Biochem Pharmacol; 1977 Jul; 26(13):1235-40. PubMed ID: 880268
    [No Abstract]   [Full Text] [Related]  

  • 20. A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of rats.
    Lotlikar PD; Raj HG; Bohm LS; Ho LL; Jhee EC; Tsuji K; Gopalan P
    Cancer Res; 1989 Feb; 49(4):951-7. PubMed ID: 2492210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.